These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262 [TBL] [Abstract][Full Text] [Related]
4. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis. Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775 [TBL] [Abstract][Full Text] [Related]
5. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600 [TBL] [Abstract][Full Text] [Related]
6. Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles. Koizume S; Takahashi T; Yoshihara M; Nakamura Y; Ruf W; Takenaka K; Miyagi E; Miyagi Y Thromb Haemost; 2019 Jul; 119(7):1058-1071. PubMed ID: 31055798 [TBL] [Abstract][Full Text] [Related]
7. Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles. Collier ME; Maraveyas A; Ettelaie C Thromb Haemost; 2014 Apr; 111(4):647-55. PubMed ID: 24258684 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the Filamin A-Dependent Mechanisms of Tissue Factor Incorporation into Microvesicles. Collier MEW; Ettelaie C; Goult BT; Maraveyas A; Goodall AH Thromb Haemost; 2017 Nov; 117(11):2034-2044. PubMed ID: 29044292 [TBL] [Abstract][Full Text] [Related]
9. Role of the tissue factor pathway in the biology of tumor initiating cells. Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004 [TBL] [Abstract][Full Text] [Related]
10. Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells. Rondon AMR; de Almeida VH; Gomes T; Verçoza BRF; Carvalho RS; König S; Rodrigues JCF; Mermelstein CDS; Versteeg HH; Monteiro RQ Biochem Biophys Res Commun; 2018 Jul; 502(1):137-144. PubMed ID: 29787758 [TBL] [Abstract][Full Text] [Related]
11. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply. Koizume S; Miyagi Y Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417928 [TBL] [Abstract][Full Text] [Related]
12. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Strukova S Front Biosci; 2006 Jan; 11():59-80. PubMed ID: 16146714 [TBL] [Abstract][Full Text] [Related]
13. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk. Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893 [TBL] [Abstract][Full Text] [Related]
14. Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy. Hisada Y; Auriemma AC; Alexander W; Ay C; Mackman N Thromb Res; 2017 Feb; 150():65-72. PubMed ID: 28043041 [TBL] [Abstract][Full Text] [Related]
15. Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis. Almeida VH; Rondon AMR; Gomes T; Monteiro RQ Cells; 2019 Jul; 8(7):. PubMed ID: 31337034 [TBL] [Abstract][Full Text] [Related]
16. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells. Jiang X; Zhu S; Panetti TS; Bromberg ME Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547 [TBL] [Abstract][Full Text] [Related]
17. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells. Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632 [TBL] [Abstract][Full Text] [Related]
18. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer. Hu Z; Xu J; Cheng J; McMichael E; Yu L; Carson WE Oncotarget; 2017 Jan; 8(1):1481-1494. PubMed ID: 27903969 [TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII. Hu Y; Repa A; Lisman T; Yerlikaya-Schatten G; Hau C; Pabinger I; Ay C; Nieuwland R; Thaler J J Thromb Haemost; 2022 Oct; 20(10):2306-2312. PubMed ID: 35748324 [TBL] [Abstract][Full Text] [Related]
20. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size. Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]